Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 101,146 | 97,646 | -3,500 | $29.1K | $40.9K | 17.44% | +$11.9K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 2,114,444 | 2,114,444 | 0 | $16.0K | $25.3K | 10.78% | +$9.3K |
| Jazz Pharmaceuticals plc(JAZZ) | 164,816 | 167,816 | +3,000 | $17.5K | $22.1K | 9.42% | +$4.6K |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 405,450 | +405,450 | $0 | $22.0K | 9.36% | +$22.0K |
| Exelixis, Inc.(EXEL) | 493,526 | 518,526 | +25,000 | $21.8K | $21.4K | 9.12% | -$337 |
| Supernus Pharmaceuticals, Inc.(SUPN) | 472,376 | 363,479 | -108,897 | $14.9K | $17.4K | 7.40% | +$2.5K |
| Sanofi(SNY) | 148,946 | 323,946 | +175,000 | $7.2K | $15.3K | 6.51% | +$8.1K |
| Avadel Pharmaceuticals | 958,877 | 955,860 | -3,017 | $8.5K | $14.6K | 6.22% | +$6.1K |
| GSK plc(GSK) | 271,729 | 271,729 | 0 | $10.4K | $11.7K | 5.00% | +$1.3K |
| Cardinal Health, Inc.(CAH) | 133,745 | 73,745 | -60,000 | $22.5K | $11.6K | 4.93% | -$10.9K |
| Indivior Plc | 974,474 | 339,532 | -634,942 | $14.4K | $8.2K | 3.49% | -$6.2K |
| BioNTech SE(BNTX) | 73,382 | 79,366 | +5,984 | $7.8K | $7.8K | 3.33% | +$14 |
| Alkermes plc(ALKS) | 207,822 | 207,822 | 0 | $5.9K | $6.2K | 2.66% | +$289 |
| Vanda Pharmaceuticals Inc.(VNDA) | 1,024,883 | 1,180,388 | +155,505 | $4.8K | $5.9K | 2.51% | +$1.1K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 4,000 | 4,000 | 0 | $2.1K | $2.2K | 0.96% | +$149 |
| Biogen Inc.(BIIB) | 0 | 10,000 | +10,000 | $0 | $1.4K | 0.60% | +$1.4K |
| Evolus, Inc.(EOLS) | 0 | 100,000 | +100,000 | $0 | $614 | 0.26% | +$614 |
| Johnson & Johnson(JNJ) | 40,000 | 0 | -40,000 | $6.1K | $0 | — | -$6.1K |